Astra has agreed a deal that could be worth almost £4billion with a Chinese company to use AI in the production of new treatments for chronic diseases.Read More

You might also be interested in reading MicroStrategy’s Bitcoin Purchases Tend to Be Short-Term Negative for Prices, Research Shows.